Birdwatch Note
2022-11-07 18:05:16 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The WHO concludes there is not yet enough evidence to recommend bivalent boosters over original versions and that "available data are not sufficient to support the issuance of any preferential recommendation for bivalent variant-containing vaccine boosters." https://medicalxpress.com/news/2022-10-preferential-omicron-covid-jabs-experts.html https://health.economictimes.indiatimes.com/news/industry/no-preferential-nod-for-omicron-covid-jabs-who-experts/94804483
Written by EB1CA753192CAB8BB4C7140533CE1C71
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1586059674570305536
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1589680399722377216
- noteId - 1589680399722377216
- participantId - EB1CA753192CAB8BB4C7140533CE1C71
- noteAuthorParticipantId -
- createdAtMillis - 1667844316783
- tweetId - 1586059674570305536
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The WHO concludes there is not yet enough evidence to recommend bivalent boosters over original versions and that "available data are not sufficient to support the issuance of any preferential recommendation for bivalent variant-containing vaccine boosters." https://medicalxpress.com/news/2022-10-preferential-omicron-covid-jabs-experts.html https://health.economictimes.indiatimes.com/news/industry/no-preferential-nod-for-omicron-covid-jabs-who-experts/94804483
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-11-07 18:05:16 UTC (1667844316783) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
EB1CA753192CAB8BB4C7140533CE1C71 | ||
2022-11-07 18:05:16 UTC (1667844316783) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
C73C7F685A58EE17B470DD7ADE00FC9F87B7B238E952A43D71C9D3571D05DD7E |
Note Ratings
rated at | rated by | |
2022-11-07 12:31:31 -0600 | 028F48873A5696E7478BF402924D4B6D | Rating Details |
2022-11-07 12:35:16 -0600 | 0AB689C453F1E569091558B03440721F | Rating Details |
2022-11-07 12:08:36 -0600 | 0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | Rating Details |
2022-11-08 13:08:20 -0600 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
2022-11-08 13:00:12 -0600 | 0EA7F2F7EB85A0F33E9157CB3487AE228B3A3E746267753D0FE81E6F02CD217B | Rating Details |
2022-11-07 12:54:30 -0600 | 107AF62AB11C806F36A40BCCE250B976 | Rating Details |
2022-11-08 06:21:02 -0600 | 1366EA66D64B5DC35BB47772887968738F3DBDE3BC423440FE491FDA88B4BCC3 | Rating Details |
2022-11-07 13:11:18 -0600 | 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 | Rating Details |
2022-11-07 12:22:49 -0600 | 5245EB82578AF96DE05307D47E0E9DE3197C98CCD31DD0D4F8B336646766B56B | Rating Details |
2022-11-07 12:58:01 -0600 | 5E029615EC0F56F0AC8292EB665B1FF9ECD69BEA1F1587C53E5F90C72C918DF8 | Rating Details |
2022-11-08 13:23:12 -0600 | 6AD8E991EC5BDDB450BF6AC2F6E581F2 | Rating Details |
2022-11-07 12:57:21 -0600 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
2022-11-07 12:31:31 -0600 | 6F63CC79CAC0EDCE3AAAF0923FFC97BF7DEDD3FA0E92DB04EC111936BA5E3635 | Rating Details |
2022-11-07 12:57:03 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
2022-11-08 13:22:15 -0600 | 89955DC5EBF3ED9D3D095D581054329D | Rating Details |
2022-11-08 13:00:12 -0600 | 8D92E46314F19B71C915156DEFA4A543 | Rating Details |
2022-11-07 12:58:01 -0600 | 8DD6287026A2737B9E0770B35BC5264D | Rating Details |
2022-11-07 18:20:16 -0600 | 91F0DEE1DE7C0774041D408AFEC7ABAE | Rating Details |
2022-11-07 13:11:18 -0600 | 96E8C2705AF950E4C4C7570121F5F054 | Rating Details |
2022-11-07 13:19:41 -0600 | 9ECEA4D5B97C8B0152C543242F9B01C3D0006CD7CFE43C7C569CF115B5F5AA2D | Rating Details |
2022-11-07 12:57:21 -0600 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
2022-11-08 13:08:20 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
2022-11-07 13:41:05 -0600 | A650F0F523D2ED642A3FA1D43EC8F94750BB112AD13BC53A47E46660B41A83A3 | Rating Details |
2022-11-07 12:35:16 -0600 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2022-11-07 18:20:16 -0600 | A928D619E7FA39EC1B0A636FD3A8B1815B316BE6763A0DE3570BA03D9D8A84CD | Rating Details |
2022-11-07 15:19:19 -0600 | AD8DC42A0C7729F56C4F30E56E6262C5285C3CADAB680599CAF1924DEA605484 | Rating Details |
2022-11-07 12:06:02 -0600 | C6226C397FD47C01B6A1D4547F65D3DBFAEA4C0151BF5A7943EEF2C379FF0E52 | Rating Details |
2022-11-08 06:21:02 -0600 | D072AC56DCF85C170E0B24E7913D60D8 | Rating Details |
2022-11-07 12:08:36 -0600 | DA4507E4409ABAABB16D1F142ADEA36B | Rating Details |
2022-11-07 15:19:19 -0600 | DD716E5B0E50F0E1F626CD180E126B89 | Rating Details |
2022-11-08 13:23:12 -0600 | DFC9CFBFB86A4771BFAC049EFBA65BA3E379D1D49B035D70006B7554D43ACE1B | Rating Details |
2022-11-08 19:03:13 -0600 | EB16BFD619695609A34C9A2339FDCF9517CB85019B8E8D3E9650B2CC2F64FD49 | Rating Details |
2022-11-08 19:03:13 -0600 | ED6BAE8439E71FEC3B4983E87D72634A | Rating Details |
2022-11-08 13:22:15 -0600 | EF8DEA36645602290497A1249F95CBF9924629F3B2879677AB97296A50D089B2 | Rating Details |
2022-11-07 12:57:03 -0600 | F07C8B00116F896474C59BB5A615116A | Rating Details |
2022-11-07 12:54:30 -0600 | F1825028B1E754E85C38129A05FEA25B7B21A89DD17EDC917BEDFC6904CDA198 | Rating Details |
2022-11-07 21:04:43 -0600 | Rating Details | |
2022-11-07 21:04:43 -0600 | Rating Details | |
2022-11-07 12:08:36 -0600 | Rating Details | |
2022-11-07 12:54:30 -0600 | Rating Details | |
2022-11-08 06:21:02 -0600 | Rating Details | |
2022-11-08 13:23:12 -0600 | Rating Details | |
2022-11-07 12:58:01 -0600 | Rating Details | |
2022-11-07 12:35:16 -0600 | Rating Details | |
2022-11-08 13:22:15 -0600 | Rating Details | |
2022-11-07 13:19:41 -0600 | Rating Details | |
2022-11-07 18:20:16 -0600 | Rating Details | |
2022-11-07 12:57:21 -0600 | Rating Details | |
2022-11-07 12:22:49 -0600 | Rating Details | |
2022-11-07 12:06:02 -0600 | Rating Details | |
2022-11-07 12:57:03 -0600 | Rating Details | |
2022-11-07 15:19:19 -0600 | Rating Details | |
2022-11-08 13:00:12 -0600 | Rating Details | |
2022-11-07 13:11:18 -0600 | Rating Details | |
2022-11-08 13:08:20 -0600 | Rating Details | |
2022-11-08 19:03:13 -0600 | Rating Details | |
2022-11-07 13:41:05 -0600 | Rating Details |